Stock ENVB ENVERIC BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Enveric Biosciences, Inc.

Equities

ENVB

US29405E2081

Real-time Estimate Cboe BZX
Other stock markets
 11:38:56 2024-05-23 am EDT 		5-day change 1st Jan Change
0.832 USD +0.24% Intraday chart for Enveric Biosciences, Inc. -8.88% -36.92%
May. 14 Firefly Neuroscience Names David Johnson Executive Chairman, Following WaveDancer Merger MT
May. 14 Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with Mindbio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Firefly Neuroscience Names David Johnson Executive Chairman, Following WaveDancer Merger
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with Mindbio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
Enveric Biosciences, Inc. Announces Signing of Non-Binding Term Sheet with Undisclosed License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Sector Update: Health Care Stocks Rise Late Afternoon
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading
Enveric Biosciences Signs Licensing Term Sheets for Joint Disease Treatment Compounds; Shares Rise
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
Enveric Biosciences Issues 228,690 Shares in Direct Offering
Top Midday Gainers
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session
Sector Update: Health Care Stocks Rise in Late Afternoon
Sector Update: Health Care Stocks Advance Friday Afternoon
Enveric Biosciences Surging on Plans to Sell Cannabinoid IP Portfolio, Focus Shift to Psilocin Therapies
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
Enveric Bioscience Generates $1.8 Million as Investors Exercise Warrants
Sector Update: Health Care Stocks Rise in Late Afternoon
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENVB Stock
  4. News Enveric Biosciences, Inc.
  5. Other languages